On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site

Scholarly Works

• Sun, X.; Li, H.; Chen, Z.; Zhang, Y.; Wei, Z.; Xu, H.; Liao, Y.; Jiang, W.; Ge, Y.; Zheng, L.; Li, T.; Wu, Y.; Luo, M.; Fang, L.; Dong, X.; Xiao, M.; Han, L.; Jia, Q.; Zhu, F. PDCdb: the biological activity and pharmaceutical information of peptide-drug conjugate (PDC). Nucleic acids research 2024. doi:10.1093/nar/gkae859
• Moukalled, N.; Abou Dalle, I.; El Cheikh, J.; Ye, Y.; Malarad, F.; Mohty, M.; Bazarbachi, A. The emerging role of melflufen and peptide-conjugates in multiple myeloma. Current opinion in oncology 2024, 36, 583–592. doi:10.1097/cco.0000000000001090
• Vrettos, E. Ι.; Kyrkou, S. G.; Zoi, V.; Giannakopoulou, M.; Chatziathanasiadou, M. V.; Kanaki, Z.; Agalou, A.; Bistas, V.-P.; Kougioumtzi, A.; Karampelas, T.; Diamantis, D. A.; Murphy, C.; Beis, D.; Klinakis, A.; Tamvakopoulos, C.; Kyritsis, A. P.; Alexiou, G. A.; Tzakos, A. G. A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine. Chemistry (Weinheim an der Bergstrasse, Germany) 2024, 30, e202401327. doi:10.1002/chem.202401327
• Ruggirello, C.; Mörl, K.; Grüttner, C.; Teller, H.; Beck-Sickinger, A. G. Selective delivery of neuropeptide Y peptides linked to magnetic particles for hyperthermia application. Journal of Organometallic Chemistry 2024, 1016, 123256. doi:10.1016/j.jorganchem.2024.123256
• Ricardo, M. G.; Llanes, D.; Rennert, R.; Jänicke, P.; Rivera, D. G.; Wessjohann, L. A. Improved Access to Potent Anticancer Tubulysins and Linker-Functionalized Payloads Via an All-On-Resin Strategy. Chemistry (Weinheim an der Bergstrasse, Germany) 2024, 30, e202401943. doi:10.1002/chem.202401943
• Rizvi, S. F. A.; Zhang, H.; Fang, Q. Engineering peptide drug therapeutics through chemical conjugation and implication in clinics. Medicinal research reviews 2024, 44, 2420–2471. doi:10.1002/med.22046
• Jia, L.; Yang, H.; Liu, Y.; Zhou, Y.; Li, G.; Zhou, Q.; Xu, Y.; Huang, Z.; Ye, F.; Ye, J.; Liu, A.; Ji, C. Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer. Journal of nanobiotechnology 2024, 22, 198. doi:10.1186/s12951-024-02460-1
• Bhuniya, S.; Vrettos, E. I. Hypoxia-Activated Theragnostic Prodrugs (HATPs): Current State and Future Perspectives. Pharmaceutics 2024, 16, 557. doi:10.3390/pharmaceutics16040557
• Zhang, J.; Hu, F.; Aras, O.; Chai, Y.; An, F. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs. ChemMedChem 2024, 19, e202300720. doi:10.1002/cmdc.202300720
• Zhou, L.; Lu, Y.; Liu, W.; Wang, S.; Wang, L.; Zheng, P.; Zi, G.; Liu, H.; Liu, W.; Wei, S. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice. Experimental hematology & oncology 2024, 13, 26. doi:10.1186/s40164-024-00493-8
• Budka, J.; Debowski, D.; Mai, S.; Narajczyk, M.; Hac, S.; Rolka, K.; Vrettos, E. I.; Tzakos, A. G.; Inkielewicz-Stepniak, I. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2024, 16, 283. doi:10.3390/pharmaceutics16020283
• Guo, X.-Y.; Yi, L.; Yang, J.; An, H.-W.; Yang, Z.-X.; Wang, H. Self-assembly of peptide nanomaterials at biointerfaces: molecular design and biomedical applications. Chemical communications (Cambridge, England) 2024, 60, 2009–2021. doi:10.1039/d3cc05811e
• Wang, Y.; Zhang, L.; Liu, C.; Luo, Y.; Chen, D. Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies. Pharmaceutics 2024, 16, 240. doi:10.3390/pharmaceutics16020240
• Mező, G.; Gomena, J.; Ranđelović, I.; Dókus, E. L.; Kiss, K.; Pethő, L.; Schuster, S.; Vári, B.; Vári-Mező, D.; Lajkó, E.; Polgár, L.; Kőhidai, L.; Tóvári, J.; Szabó, I. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview. International journal of molecular sciences 2024, 25, 1864. doi:10.3390/ijms25031864
• Rizvi, S. F. A.; Zhang, L.; Zhang, H.; Fang, Q. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic. ACS pharmacology & translational science 2024, 7, 309–334. doi:10.1021/acsptsci.3c00269
• Zeng, W.; Xue, J.; Geng, H.; Liu, X.; Yang, J.; Shen, W.; Yuan, Y.; Qiang, Y.; Zhu, Q. Research progress on chemical modifications of tyrosine residues in peptides and proteins. Biotechnology and bioengineering 2023, 121, 799–822. doi:10.1002/bit.28622
• Ahmed, Y. W.; Tsai, H.-C.; Wu, T.-Y.; Darge, H. F.; Chen, Y.-S. Role of thermal and reactive oxygen species-responsive synthetic hydrogels in localized cancer treatment (bibliometric analysis and review). Materials Advances 2023, 4, 6118–6151. doi:10.1039/d3ma00341h
• Sviben, I.; Glavaš, M.; Erben, A.; Bachelart, T.; Pavlović Saftić, D.; Piantanida, I.; Basarić, N. Dipeptides Containing Pyrene and Modified Photochemically Reactive Tyrosine: Noncovalent and Covalent Binding to Polynucleotides. Molecules (Basel, Switzerland) 2023, 28, 7533. doi:10.3390/molecules28227533
• Koutsopetras, I.; Mishra, A. K.; Benazza, R.; Hernandez-Alba, O.; Cianférani, S.; Chaubet, G.; Nicolai, S.; Waser, J. Cysteine-Cysteine Cross-Conjugation of both Peptides and Proteins with a Bifunctional Hypervalent Iodine-Electrophilic Reagent. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202302689. doi:10.1002/chem.202302689
• Biniari, G.; Markatos, C.; Nteli, A.; Tzoupis, H.; Simal, C.; Vlamis-Gardikas, A.; Karageorgos, V.; Pirmettis, I.; Petrou, P.; Venihaki, M.; Liapakis, G.; Tselios, T. Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. International journal of molecular sciences 2023, 24, 15232. doi:10.3390/ijms242015232

Explore citations to this article at